Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Molecular Biology Techniques and Applications, and Genetic factors in colorectal cancer.
Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patients
ctDNA monitoring using tumor-informed copy number analysis.
Cell-free DNA size deconvolution resolves nucleosomal origins and reveals tumor-associated fragmentomic alterations.
ctDNA monitoring using tumor-informed copy number analysis
Cell-free DNA size deconvolution resolves nucleosomal origins and reveals tumor-associated fragmentomic alterations
Promises and pitfalls of multi-cancer early detection using liquid biopsy tests
A standardized framework for robust fragmentomic feature extraction from cell-free DNA sequencing data
Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study
A large‐scale retrospective study in metastatic breast cancer patients using circulating tumour <scp>DNA</scp> and machine learning to predict treatment outcome and progression‐free survival
260 Second Primary Lung Cancer Cohort Study (SPORT)
Detecting circulating tumor DNA in archived whole blood samples in patients undergoing treatment for primary cutaneous melanoma
Abstract 4550: Dried blood sot sampling as a minimally invasive and accessible method for investigating circulating tumor DNA in diverse cancer settings
A mathematical model of cell-free DNA fragment size reveals cancer-specific fragmentomic patterns
Genomic Profiles of Early-Stage Non-Small Cell Lung Cancer Patients, and Association with Pre-Treatment Blood Circulating Tumour DNA Detection and Levels
Second Primary Lung Cancer – An Emerging Issue in Lung Cancer Survivors
LIBELULE: A Randomized Phase III Study to Evaluate the Clinical Relevance of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer
Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer
Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer
HERD: A multi-centre prospective cohort study to facilitate early detection of relapse in radically treated, high risk head and neck squamous cell carcinoma.
S138 Multiparametric investigation and stratification of indeterminate lung nodules (MISIL1)
Second Primary Lung Cancer—Potential Areas of Ambiguity
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer
Comparison of tumor‐informed and tumor‐naïve sequencing assays for ctDNA detection in breast cancer
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancer.
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer.
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial
235TiP Hamlet.rt Trans: Prospective single-centre translational study evaluating liquid biomarkers of radiation response
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.
A large-scale retrospective study in metastatic breast cancer patients using circulating tumor DNA and machine learning to predict treatment outcome and progression-free survival